Home › Nausea and Vomiting › Texas
Nausea and Vomiting clinical trials in Texas
6 studies for Nausea and Vomiting are looking for participants at sites in Texas.
Cities in Texas
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Alina Clinical Trials, LLC., Dallas
- North Texas Center for Clinical Research, Frisco
- DM Clinical Research - Cy Fair, Houston
- and 6 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 28, 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dell Children's Medical Center, Austin
- Houston Clinical Trials, LLC, Bellaire
- FutureSearch Trials of Dallas, LLC, Dallas
- and 5 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dell Children's Medical Center, Austin
- Child Neurology Consultants of Austin - Central Austin, Austin
- Houston Clinical Trials, LLC, Bellaire
- and 4 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- World Research Link, Baytown
- John Peter Smith Hospital, Fort Worth
- Kelsey-Seybold Clinic, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07169851Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
- Baylor College of Medicine, Houston
Recruiting
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT06464926A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
- Vanda Investigational Site, Plano
- Vanda Investigational Site, San Antonio
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Apr 20, 2026 · NCT07446439From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.